Bioelectronics Corp (BIEL)

[edbi46]

NOT according to ME, my Friends, that i persuaded to buy in ( 2 of them are more, than $200000 in, one lives in Seoul, SK, knows an Att, one of Her clients works for one of the signed Companies - more, than 500 employees - that person started buying in June, this year, and so are 2 of his KNOWN co-workers, so, what about their Friends&Families?? I would gladly provide names, links, financial statements, but you know that's not possible.......but knowing him for 25 years, i would say it is 99.9% accurate........ So......there ), according to their Friends&Families, Respectable People with WORKING BRAINS, Sources, Analysts, FDA, according to 5 ( FIVE ) Companies ( there could even be more as of now ) that are signed with BIEL -- this Company is a WINNER and Actipatch ABSOLUTELY is marketable !!!
BIEL$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

ATTENTION, People, NEWBIES especially !!!!!!! DO YOUR OWN, INTELLIGENT DD !!!! Go to bielcorp.com, read all the news, financials ( NOT that the latter will matter in ANY WAY!! ), research Actipatch on Google, Amazon, Wallmart, Ebay....etc.....read ALL the reviews ( POSITIVE / NEGATIVE ) and only then make your OWN, INTELLIGENT DECISION ( REMEMBER: more noise there is - BIGGER CHANCE of the NEWS and acceleration of the PPS ) !!!!!!!!!!!!!! GLTAY
BIEL$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

BioElectronics's drug-free pain therapy devices Ok'd in Europe
Nov. 12, 2020 8:14 AMBioElectronics Corporation (BIEL)By: Vandana Singh, SA News Editor
BioElectronics (OTCPK:BIEL) has received the CE Mark for its ActiPatch and RecoveryRx Pulsed Shortwave Therapy (PSWT) wearable medical devices.

The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain.

The certification for the CE mark is valid until May, 2024
https://www.bielcorp.com/bioelectronics-earns-ce-mark-for-the-actipatch-and-recoveryrx-drug-free-pain-therapy-devices/

BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage
Drug-Free Pain Relief Technology with Premium Wraps

NEWS PROVIDED BY

BioElectronics Corporation
Nov 06, 2020, 08:05 ET

SHARE THIS ARTICLE


FREDERICK, Md., Nov. 6, 2020 /PRNewswire/ -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS http://scottspecialties.com/) to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO www.djoglobal.com) Advantage product line.

This commercial partnership will leverage the ActiPatch's broad indications for use and offer an active-passive treatment combination product to treat pain, increase physical functionality and improve overall quality of life. The new products will be marketed under DJO's DonJoy Advantage (DJA) line of orthopedic appliances and sold as an EME Knee Wrap and an EME Back Wrap," powered by ActiPatch". In January 2020, BioElectronics obtained a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the drug free ActiPatch® medical device, for the indication: "adjunctive treatment of musculoskeletal pain." With the latest clearance, ActiPatch remains the only pulsed shortwave therapy (PSWT) device with an over-the-counter clearance for treating any form of musculoskeletal pain.

Keith Nalepka, VP Sales and Marketing for BioElectronics expressed his enthusiasm for the market opportunity: "This is a great opportunity for the ActiPatch brand. We have executed on our OEM strategy by partnering with Scott Specialties this past spring and leveraging their relationship with DJO to drive ActiPatch sales. During the pandemic we have seen consumers continuing to seek alternatives to oral medicines for pain. By partnering with Scott Specialties and another soon-to-be-announced, major sports medicine company, we are confident that these innovative product offerings will meet the need for a growing demand."

Kelly Whelan, President of BioElectronics, stated "We are thrilled to have the marketing strength of DonJoy Advantage coupled with the power of ActiPatch in products available to consumers online now at www.donjoyperformance.com. A soft launch in retail outlets is scheduled for December and the products will be promoted by DJO's sales force in Q1, 2021."

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy.

About Scott Specialties Inc

Scott Specialties Inc. is a Kansas-based manufacturer of orthopedic soft goods and supplies their products to global orthopedic companies.
https://www.bielcorp.com/bioelectronics-actipatch-therapy-to-be-marketed-by-donjoy-advantage/